Access your Health Cash Plan and Breeze accounts here.
We ensure the dates of these reviews are published here and readily available with key findings of approved reviews. When combined with other referenced materials, this information should be sufficient to help give a good understanding of the product’s value, target market, and target audience. We are committed to maintaining the quality and value of our products. Should this not be the case we will inform you promptly of the outcome and any decisions made during our reviews.
To help you understand this further, Health Shield’s product development process can be found here.
In order to complete these reviews, we use a range of metrics these including the following:
All member claims are handled in-house.
The outcome of the value assessments for each product should be read in conjunction with the product Target Market Statements which can be found within our Broker Hub, for each product.
The Target Market Statements provide Target Audience, Eligibility and for whom it’s not suitable.
Within the Broker Hub, you’ll also find our wider policy literature, including Membership Plan, Product Guides (where applicable) and Policy Documents.
Product Reviewed |
Date of Review |
Outcome |
Date of |
Response |
Flex Extra |
May 2024 |
Approved |
May 2025 |
Product is providing intended fair value to members and is suitable to continue to be distributed |
Classic 3-9 |
June 2024 |
Approved |
June 2025 |
Product is providing intended fair value to members and is suitable to continue to be distributed. |
Classic 10+ |
June 2024 |
Approved |
June 2025 |
Product is providing intended fair value to members and is suitable to continue to be distributed |
Corporate |
September 2023 |
Approved |
September 2024 |
Product is providing intended fair value to members and is suitable to continue to be distributed |
Tailored |
June 2024 |
Approved |
June 2025 |
Product is providing intended fair value to members and is suitable to continue to be distributed |
Select 3-9 |
July 2024 |
Approved |
July 2025 |
Product is providing intended fair value to members and is suitable to continue to be distributed |
Select 10+ |
July 2024 |
Approved |
July 2025 |
Product is providing intended fair value to members and is suitable to continue to be distributed |
As part of our Annual Product Review Health Shield will reach out for you to complete our standard Distributor Checklist. This will include Product Information Target Market and will need to be completed to clarify the following:
You can find Target Market Statements and product collateral in our Broker Hub. Please contact your Health Shield Account Manager if you have any queries regarding the products.